Drug-eluting embolic microspheres for local drug delivery - State of the art.

Details

Serval ID
serval:BIB_95DABA36AF50
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Drug-eluting embolic microspheres for local drug delivery - State of the art.
Journal
Journal of controlled release
Author(s)
Fuchs K., Duran R., Denys A., Bize P.E., Borchard G., Jordan O.
ISSN
1873-4995 (Electronic)
ISSN-L
0168-3659
Publication state
Published
Issued date
28/09/2017
Peer-reviewed
Oui
Volume
262
Pages
127-138
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
Embolic microspheres or beads used in transarterial chemoembolization are an established treatment method for hepatocellular carcinoma patients. The occlusion of the tumor-feeding vessels by intra-arterial injection of the beads results in tumor necrosis and shrinkage. In this short review, we describe the utility of using these beads as devices for local drug delivery. We review the latest advances in the development of non-biodegradable and biodegradable drug-eluting beads for transarterial chemoembolization. Their capability to load different drugs, such as chemotherapeutics and anti-angiogenic compounds with different physicochemical properties, like charge and hydrophilicity/hydrophobicity, are discussed. We specifically address controlled and sustained drug release from the microspheres, and the resulting in vivo pharmacokinetics in the plasma vs. drug distribution in the targeted tissue.
Keywords
Animals, Chemoembolization, Therapeutic, Delayed-Action Preparations/pharmacokinetics, Delayed-Action Preparations/therapeutic use, Drug Delivery Systems, Humans, Microspheres, Antiangiogenic, Bevacizumab (PubChem CID: 24801580), Biodegradable, Cisplatin (PubChem CID 441203), Controlled release, Degradable, Doxorubicin Hydrochloride (PubChem CID: 443939), Drug-eluting beads, Hepatocellular carcinoma, Ibuprofen (PubChem CID: 3672), Irinotecan (PubChem CID: 60838), Local delivery, N-Desethyl Sunitinib (PubChem CID: 10292573), Pharmacokinetics, Rapamycin (PubChem CID: 5284616), Sorafenib (PubChem CID: 216239), Sunitinib (PubChem CID: 5329102), Transarterial chemoembolization, Vandetanib (PubChem CID: 3081361)
Pubmed
Web of science
Create date
02/08/2017 15:18
Last modification date
20/08/2019 15:58
Usage data